No Data
No Data
Shanghai No.1 Pharmacy Co., Ltd. Announcement of 2024 Semi-Annual Performance Forecast.
Shanghai No.1 Pharmacy (600833.SH) has released a profit forecast, with an expected net income of 1.15 to 1.45 billion yuan in the first half of the year, a year-on-year increase of 150.93% to 216.39%.
Shanghai No. 1 Pharmacy (600833.SH) has released its performance forecast for the first half of 2024 and is expected to achieve...
Shanghai No.1 Pharmacy (600833.SH) plans to distribute a dividend of 0.125 yuan per share on June 21.
Shanghai No.1 Pharmacy (600833.SH) announced that the equity distribution for the fiscal year 2023 is planned to be: cash dividend of RMB … per A-share.
First Pharmaceutical (600833.SH) announced first-quarter results, net profit of 36.5538 million yuan, a year-on-year increase of 21.75%
First Pharmaceutical (600833.SH) disclosed its report for the first quarter of 2024. The company achieved operating income during the reporting period...
Weak Statutory Earnings May Not Tell The Whole Story For Shanghai No.1 PharmacyLtd (SHSE:600833)
First Pharmaceutical (600833.SH): Net profit in 2023 fell 37.81% year-on-year, and plans to distribute 1.25 yuan to 10 shares
On March 29, Ge Longhui (600833.SH) released its 2023 annual report. Operating revenue was 1.8 billion yuan, down 31.49% year on year, net profit was 89.275 million yuan, down 37.81% year on year, after deducting non-net profit of 10.875,800 yuan, down 92.23% year on year, with basic earnings of 0.40 yuan per share. A cash dividend of 1.25 yuan is distributed to all shareholders of the company for every 10 shares.
No Data